Low protein diet is an important part of management of chronic kidney disease. Supplementation of ketoanalogue allows further restriction of daily protein intake to a lower level. Ketoanalogue can be transformed to essential amino acid through transamination reaction and can also reduce uremic toxin formation. Studies demonstrate it can delay renal deterioration and the time of dialysis initiation. With closed medical and nutritional monitoring, very low protein diet accompanied with ketoanalogue is unlikely to cause malnutrition or increased mortality. Good dietary compliance is the key to success of low protein diet treatment. It depends on the efforts of both medical caregivers and patients to achieve a better outcome.